---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-022880"
form_type: "8-K"
ticker: "NAII"
cik: "0000787253"
company_name: "NATURAL ALTERNATIVES INTERNATIONAL INC"
filed_at: "2022-09-22T23:59:59+00:00"
generated_at: "2026-06-23T08:09:51.841287+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Natural Alternatives Q4 net sales up 18% to $52.5M; guides FY2023 sales growth 10-15%

## Summary
- Q4 net sales $52.5M (+18.3% YoY); net income $3.1M ($0.52 diluted EPS) vs $3.0M ($0.47) in Q4 FY2021.
- Full-year FY2022 net sales $171.0M (-4.2%); net income $10.7M ($1.74 diluted EPS) vs $10.8M ($1.69) in prior year.
- Private-label contract manufacturing Q4 up 25.6% to $49.9M; new e-commerce customer drove increase.
- CarnoSyn royalty/licensing/raw material sales Q4 down 43.6% to $2.6M due to market/seasonal factors.
- Guidance: FY2023 net sales +10-15%, operating income 5-7% of sales; inflation headwinds noted.

## SEC filing metadata
- accession: 0001437749-22-022880
- form_type: 8-K
- ticker: NAII
- cik: 0000787253
- company_name: NATURAL ALTERNATIVES INTERNATIONAL INC
- filed_at: 2022-09-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/787253/000143774922022880/0001437749-22-022880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/787253/000143774922022880/naii20220921_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-022880
- JSON: https://secwatch.observer/filing/0001437749-22-022880.json
- Plain text: https://secwatch.observer/filing/0001437749-22-022880.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.